Medicines-Nervous System Treatment-Antivirus-SkQ1 Antioxidants-Coxibes-Nootropic

Cerebrovascular diseases: - acute disorders of cerebral circulation in the acute and early rehabilitation period of the course of the disease as part of complex therapy.

OLANZAPINEВ® (Zyprexa) 10 mg/tab, 28 tabs

MEBICARВ® (Adaptol, Mebicarum) 300 mg/tab, 20 tabs

Strattera (Atomoxetine) acts on certain chemicals in the brain which are responsible for hyperactive behaviour and the ability to control impulses. It is used in combination with counselling and therapy to treat patients affected by ADHD (attention deficit hyperactivity disorder).

Dilaxa (Celecoxib) capsules Coxibes 100mg 10 capsules, 200mg 10 capsules, 200mg 30 capsules,

Celebrex (Celecoxib) capsules Coxibes 100mg 10 capsules, 200mg 10 capsules, 200mg 30 capsules,

Rowcoxib-Rowtech (Celecoxib) 200mg 10 capsules Coxibes

The anxiolytic (tranquilizing) agent of the non-benzodiazepine series also has an antidepressant effect. Unlike classical anxiolytics, it does not have antiepileptic, sedative, hypnotic and muscle relaxant effects.

Pharmacological action - anxiolytic, anticonvulsant, muscle relaxant, sedative, hypnotics. A single dose is 0.0005? 0.001 g (0.5? 1 mg), and in sleep disorders? 0.00025? 0.0005 g (0.25? 0.5 mg) 20-30 minutes before bedtime. Maximum daily dose? 0.01 g (10 mg).

Coronavir tablets p.p. 200mg 50pcs Antiviral agent

AREPLIVIR (FAVIPIRAVIR) is a direct antiviral drug recommended by the Ministry of Health of the Russian Federation for the treatment of COVID-19 of any severity. FAVIPIRAVIR is an inhibitor of RNA-dependent-RNA polymerase (RdRp), an enzyme that is necessary for the reproduction of the virus.